A high-risk period for cerebrovascular events exists after transcatheter aortic valve implantation

JACC: Cardiovascular Interventions

Volumn 4, Issue 12, 2011, Pages 1290-1297

  Tay, Edgar L W ^a   Gurvitch, Ronen ^a   Wijesinghe, Namal ^a   Nielispach, Fabian ^a   Wood, David ^a   Cheung, Anson ^a   Ye, Jian ^a   Lichtenstein, Samuel V ^a   Carere, Ronald ^a   Thompson, Christopher ^a   Webb, John G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

antiplatelet therapy; antithrombotic therapy; percutaneous aortic valve replacement; stroke; transient ischemic attack(s)

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HEPARIN; WARFARIN;

AGED; ARTICLE; CARDIOLOGIST; CEREBROVASCULAR DISEASE; CIGARETTE SMOKING; CONTINUING EDUCATION; DEATH; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPOTENSION; IMPLANTATION; INCIDENCE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STROKE; SURVIVAL; THROMBOEMBOLISM; THROMBOSIS; THROMBOSIS PREVENTION; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; BRITISH COLUMBIA; CEREBROVASCULAR DISORDERS; CHI-SQUARE DISTRIBUTION; FEMALE; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MALE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84255172532     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2011.08.012     Document Type: Article

References (27)

1. J.G. Webb, L. Altwegg, R.H. Boone Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes Circulation 119 2009 3009 3016
2. D. Himbert, F. Descoutures, N. Al-Attar Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis J Am Coll Cardiol 54 2009 303 311
3. J.D. Salazar, R.J. Wityk, M.A. Grega Stroke after cardiac surgery: short- and long-term outcomes Ann Thorac Surg 72 2001 1195 1201 discussion 12012 (Pubitemid 32938005)
4. M. Gotzmann, T. Hehen, A. Germing Short-term effects of transcatheter aortic valve implantation on neurohormonal activation, quality of life and 6-minute walk test in severe and symptomatic aortic stenosis Heart 96 2010 1102 1106
5. J.G. Webb, M. Chandavimol, C.R. Thompson Percutaneous aortic valve implantation retrograde from the femoral artery Circulation 113 2006 842 850
6. S.V. Lichtenstein, A. Cheung, J. Ye Transapical transcatheter aortic valve implantation in humans: initial clinical experience Circulation 114 2006 591 596 (Pubitemid 44202060)
7. N. Piazza, E. Grube, U. Gerckens Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval EuroIntervention 4 2008 242 249
8. M.B. Leon, C.R. Smith, M. Mack PARTNER Trial Investigators Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery N Engl J Med 363 2010 1597 1607
9. C.R. Smith, M.B. Leon, M.J. Mack PARTNER Trial Investigators Transcatheter versus surgical aortic-valve replacement in high-risk patients N Engl J Med 364 2011 2187 2198
10. M. Heras, J.H. Chesebro, V. Fuster High risk of thromboemboli early after bioprosthetic cardiac valve replacement J Am Coll Cardiol 25 1995 1111 1119
11. Percutaneous balloon aortic valvuloplasty Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry Circulation 84 1991 2383 2397
12. W. Oder, P. Siostrzonek, W. Lang Distribution of ischemic cerebrovascular events in cardiac embolism Klin Wochenschr 69 1991 757 762
13. R.C. Becker, P. Eisenberg, A.G. Turpie Pathobiologic features and prevention of thrombotic complications associated with prosthetic heart valves: fundamental principles and the contribution of platelets and thrombin Am Heart J 141 2001 1025 1037 (Pubitemid 32477017)
14. L.A. Harker, S.J. Slichter, L.R. Sauvage Platelet consumption by arterial prostheses: the effects of endothelialization and pharmacologic inhibition of platelet function Ann Surg 186 1977 594 601 (Pubitemid 8215901)
15. A. Linke, R. Höllriegel, T. Walther Ingrowths of a percutaneously implanted aortic valve prosthesis (CoreValve) in a patient with severe aortic stenosis Circ Cardiovasc Interv 1 2008 155 158
16. P.H. Grewe, T. Deneke, S.K. Holt, A. Machraoui, J. Barmeyer, K.M. Muller [Scanning electron microscopic analysis of vessel wall reactions after coronary stenting] Z Kardiol 89 2000 21 27 (Pubitemid 30080034)
17. R.O. Bonow, B.A. Carabello, C. Kanu ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease) J Am Coll Cardiol 48 2006 e1 e148
18. T.A. Orszulak, H.V. Schaff, C.J. Mullany Risk of thromboembolism with the aortic Carpentier-Edwards bioprosthesis Ann Thorac Surg 59 1995 462 468
19. T.M. Sundt, K.J. Zehr, J.A. Dearani Is early anticoagulation with warfarin necessary after bioprosthetic aortic valve replacement? J Thorac Cardiovasc Surg 129 2005 1024 1031 (Pubitemid 40631422)
20. T. Gherli, A. Colli, C. Fragnito Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study Circulation 110 2004 496 500 (Pubitemid 39036177)
21. W. Mistiaen, P. Van Cauwelaert, P. Muylaert, S.U. Sys, F. Harrisson, H. Bortier Thromboembolic events after aortic valve replacement in elderly patients with a Carpentier-Edwards perimount pericardial bioprosthesis J Thorac Cardiovasc Surg 127 2004 1166 1170 (Pubitemid 38451953)
22. D. Toni, M. Fiorelli, S. Bastianello Hemorrhagic transformation of brain infarct: predictability in the first 5 hours from stroke onset and influence on clinical outcome Neurology 46 1996 341 345 (Pubitemid 26081310)
23. Z. Khurram, E. Chou, R. Minutello Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding J Invasive Cardiol 18 2006 162 164 (Pubitemid 44576090)
24. P.M. Rothwell, J. Slattery, C.P. Warlow A systematic review of the risks of stroke and death due to endarterectomy for symptomatic carotid stenosis Stroke 27 1996 260 265 (Pubitemid 26044497)
25. P. Kahlert, S.C. Knipp, M. Schlamann Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study Circulation 121 2010 870 878
26. A. Ghanem, A. Mller, C.P. Nhle Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging J Am Coll Cardiol 55 2010 1427 1432
27. M.B. Leon, N. Piazza, E. Nikolsky Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium J Am Coll Cardiol 57 2011 253 269